[Ip-health] Mercosur/EU FTA - study and video released about impact on access to medicines in Brazil

marcela vieira marcelacfvieira at gmail.com
Wed Mar 22 09:46:37 PDT 2017


Study & video released about the impact of the Mercosur/EU FTA on access to
medicines in Brazil

This week (March 20-24, 2017) negotiators of the European Union and Mercosur
meet once again to move forward with the negotiation of a Free Trade
Agreement (FTA). This FTA could have a great impact not only on trade, but
in people's rights, including access to medicines.

This round of negotiations, that is taking place in Buenos Aires, Argentina,
occurs after the European Commission has released its proposal on the
chapter on intellectual property during the last round that took place in
Brussels on October 2016.

The EU proposal on intellectual property has some measures that go beyond
the WTO TRIPS agreement and that could jeopardize the access to medicines
in all countries involved in the negotiations!

It is critical that Mercosur countries tell the European Commission
that they will not accept any “TRIPS-plus” measure and any measure
that could endanger access to medicines.

The National School of Public Health of Fiocruz (ENSP), a public
research institute
in Brazil, has conducted a study to identify the TRIPS-plus measures
contained in the proposal and the negative impact that it could have on the
public purchases of
medicines in Brazil. This study was conducted with the support of the
Shuttleworth
Foundation.

The preliminary results of this study are available here (in Portuguese):
http://bit.ly/ftaeumercosur1.

A video highlighting the main findings of the study and worries around the
FTA negotiations is available here (in English, with Portuguese subtitles):
https://vimeo.com/209577201


Best,
Marcela Fogaça Vieira
co-author of the study



More information about the Ip-health mailing list